Armando Magrelli

1.9k total citations
33 papers, 1.0k citations indexed

About

Armando Magrelli is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Armando Magrelli has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Armando Magrelli's work include CRISPR and Genetic Engineering (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and CAR-T cell therapy research (5 papers). Armando Magrelli is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and CAR-T cell therapy research (5 papers). Armando Magrelli collaborates with scholars based in Italy, Netherlands and Germany. Armando Magrelli's co-authors include Claudio Talora, G. Macino, Paola Ballario, Paola Vittorioso, Andrea Cabibbo, Domenica Taruscio, Marco Salvatore, Elisabetta Golini, Daniela Marazziti and Rafaele Matteoni and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Armando Magrelli

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armando Magrelli Italy	16	554	310	137	132	107	33	1.0k
Suzanne Hosier United States	16	512 0.9×	77 0.2×	132 1.0×	53 0.4×	88 0.8×	17	1.2k
Xia Wu China	19	704 1.3×	151 0.5×	129 0.9×	152 1.2×	90 0.8×	56	1.1k
Marjorie A. Phillips United States	22	699 1.3×	60 0.2×	218 1.6×	104 0.8×	79 0.7×	45	1.3k
Pascal Soularue France	15	987 1.8×	137 0.4×	214 1.6×	49 0.4×	446 4.2×	24	1.6k
Minoru Asada Japan	19	536 1.0×	87 0.3×	74 0.5×	86 0.7×	89 0.8×	42	1.0k
Kurt Baltensperger Switzerland	17	1.7k 3.1×	1.2k 3.7×	135 1.0×	42 0.3×	61 0.6×	20	2.2k
Martina Rossi Italy	20	614 1.1×	208 0.7×	18 0.1×	271 2.1×	87 0.8×	52	1.2k
Xuechao Feng China	19	640 1.2×	73 0.2×	82 0.6×	117 0.9×	99 0.9×	41	961
Jinsheng Weng United States	21	612 1.1×	57 0.2×	104 0.8×	116 0.9×	144 1.3×	39	1.1k
Xuyang Liu China	22	698 1.3×	58 0.2×	86 0.6×	68 0.5×	131 1.2×	120	1.6k

Countries citing papers authored by Armando Magrelli

Since Specialization

Citations

This map shows the geographic impact of Armando Magrelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armando Magrelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armando Magrelli more than expected).

Fields of papers citing papers by Armando Magrelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armando Magrelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armando Magrelli. The network helps show where Armando Magrelli may publish in the future.

Co-authorship network of co-authors of Armando Magrelli

This figure shows the co-authorship network connecting the top 25 collaborators of Armando Magrelli. A scholar is included among the top collaborators of Armando Magrelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armando Magrelli. Armando Magrelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cometa, Maria Francesca, et al.. (2024). Revolutionizing CAR T-Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and Accessibility. International Journal of Molecular Sciences. 25(19). 10365–10365. 11 indexed citations

Palomo, Gloria M., Enrico Costa, Darius Matusevičius, et al.. (2024). Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation. Gene Therapy. 31(7-8). 366–377. 5 indexed citations

Cometa, Maria Francesca, et al.. (2023). CAR-T State of the Art and Future Challenges, A Regulatory Perspective. International Journal of Molecular Sciences. 24(14). 11803–11803. 16 indexed citations

Palomo, Gloria M., Enrico Costa, Darius Matusevičius, et al.. (2023). The European landscape for gene therapies in orphan diseases: 6-year experience with the EMA Committee for Orphan Medicinal Products. Molecular Therapy. 31(12). 3414–3423. 7 indexed citations

Wolter, F, et al.. (2022). Licensing of Orphan Medicinal Products—Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021. Frontiers in Pharmacology. 13. 920336–920336. 7 indexed citations

Pedrini, Elena, V.L. Pecoraro, Maria Gnoli, et al.. (2022). Real-World Data and Budget Impact Analysis (BIA): Evaluation of a Targeted Next-Generation Sequencing Diagnostic Approach in Two Orthopedic Rare Diseases. Frontiers in Pharmacology. 13. 785705–785705. 1 indexed citations

Mariz, Segundo, et al.. (2021). Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan Designation. Frontiers in Oncology. 11. 809035–809035. 2 indexed citations

López‐Bastida, Julio, Juan Manuel Ramos-Goñi, Isaac Aranda-Reneo, et al.. (2019). Using a stated preference discrete choice experiment to assess societal value from the perspective of patients with rare diseases in Italy. Orphanet Journal of Rare Diseases. 14(1). 154–154. 15 indexed citations

Capovilla, Giuseppe, Laura Fregonese, Matthias P. Hofer, et al.. (2019). Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases. Drug Discovery Today. 25(2). 274–291. 4 indexed citations

10.

Fregonese, Laura, Matthias P. Hofer, Armando Magrelli, et al.. (2017). Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe. Drug Discovery Today. 23(1). 90–100. 15 indexed citations

11.

Stoyanova‐Beninska, Violeta, Giuseppe Capovilla, Matthias P. Hofer, et al.. (2017). Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions. Drug Discovery Today. 23(1). 26–48. 11 indexed citations

12.

Manca, Sonia, Armando Magrelli, Samantha Cialfi, et al.. (2011). Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation. Experimental Dermatology. 20(11). 932–937. 56 indexed citations

13.

Maranghi, Francesca, Stefano Lorenzetti, Roberta Tassinari, et al.. (2010). In utero exposure to di-(2-ethylhexyl) phthalate affects liver morphology and metabolism in post-natal CD-1 mice. Reproductive Toxicology. 29(4). 427–432. 49 indexed citations

14.

Zuntini, Monia, Marco Salvatore, Elena Pedrini, et al.. (2010). MicroRNA profiling of multiple osteochondromas: identification of disease‐specific and normal cartilage signatures. Clinical Genetics. 78(6). 507–516. 32 indexed citations

15.

Caprini, Elisabetta, Cristina Cristofoletti, Diego Arcelli, et al.. (2009). Identification of Key Regions and Genes Important in the Pathogenesis of Sézary Syndrome by Combining Genomic and Expression Microarrays. Cancer Research. 69(21). 8438–8446. 54 indexed citations

16.

Certo, Maria Grazia Di, Nicoletta Corbi, Georgios Strimpakos, et al.. (2009). The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. Human Molecular Genetics. 19(5). 752–760. 28 indexed citations

17.

Magrelli, Armando, Gianluca Azzalin, Marco Salvatore, et al.. (2009). Altered microRNA Expression Patterns in Hepatoblastoma Patients. Translational Oncology. 2(3). 157–163. 60 indexed citations

18.

Cialfi, Samantha, Simona Ceccarelli, Cinzia Marchese, et al.. (2009). Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease. British Journal of Dermatology. 162(3). 518–526. 31 indexed citations

19.

Marazziti, Daniela, Elisabetta Golini, Silvia Mandillo, et al.. (2004). Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor. Proceedings of the National Academy of Sciences. 101(27). 10189–10194. 78 indexed citations

20.

Magrelli, Armando, et al.. (1994). Splicing of the rolA Transcript of Agrobacterium rhizogenes in Arabidopsis. Science. 266(5193). 1986–1988. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact